CALL - SPRINTER OPEN END - ABBOTT LABORATORIES Stock

Certificat

DE000VU49HP9

Delayed Deutsche Boerse AG 01:45:12 2024-06-17 pm EDT
1.91 EUR -2.05% Intraday chart for CALL - SPRINTER OPEN END - ABBOTT LABORATORIES
Current month+10.17%
1 month-2.50%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-17 1.91 -2.05%
24-06-14 1.95 +0.52%
24-06-13 1.94 -4.90%
24-06-12 2.04 -5.99%
24-06-11 2.17 -8.05%

Delayed Quote Deutsche Boerse AG

Last update June 17, 2024 at 01:45 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VU49HP
ISINDE000VU49HP9
Date issued 2023-03-22
Strike 82.89 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.15
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.67
Lowest since issue 1.09
Spread 0.01
Spread %0.52%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus